Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

“Shots in arms” – OPT planned & coordinated to meet COVID-19 mission

Image of Military personnel sitting around a table talking. Members of the Department of Defense’s COVID-19 Operational Planning Team meet at Defense Health Agency Headquarters in Falls Church, Virginia, May 18 (Photo by: Mark Oswell, MHS Communication).

On May 24, the Department of Defense’s COVID-19 Operational Planning Team (OPT) transitioned its mission to the Coronavirus Vaccine Immunization Program (CVIP) working group.

The OPT was established last November by the Secretary of Defense and given the authority to oversee the Department of Defense's COVID-19 vaccination operations.

Under the direction of Defense Health Agency Director, Army Lt. Gen (Dr.) Ronald Place; and leadership of Army Maj. Gen. (Dr.) George "Ned" Appenzeller, DHA’s assistant director for combat support, the OPT brought together a diverse team of nearly 85 representatives from across the DOD to develop and execute the complex plan to safely and efficiently administer COVID-19 vaccines to the DOD's globally dispersed population.

The team consisted of representatives from the DHA, service branches, National Guard Bureau, Coast Guard, Joint Staff Surgeon’s Office, combatant commands, Defense Logistics Agency, and U.S. Army Medical Materiel Agency - Distribution Operations Center, and worked closely with the Countermeasures Acceleration Group (previously known as Operation Warp Speed), the DOD COVID-19 Task Force, the Department of Health And Human Services, and the Centers for Disease Control and Prevention.

The OPT focused on four priorities:

  • Protect service members
  • Protect DOD civilians and their families
  • Safeguard national security capabilities
  • Support a whole-of-nation response to the COVID-19 pandemic

From those orders, the team went to work; spending long days, nights, and weekends to formulate the COVID-19 vaccination plan for the DOD. This plan eventually grew to 512 pages consisting of 15 modifications and over 30 appendices.

"Once we got those priorities, the DOD basically said, "The OPT is responsible to support the whole-of-nation response to receive, distribute and administer COVID-19 vaccines,'" explained Air Force Col. Jennifer Garrison, OPT team leader.

Military personnel posing for a picture
Members of the Department of Defense’s COVID-19 Operational Planning Team pose with Defense Health Agency Director Army Lt. Gen. (Dr.) Ronald J. Place (fourth from right), and Maj. Gen. (Dr.) George “Ned” Appenzeller, DHA Combat Support assistant director (far left) at Defense Health Agency Headquarters in Falls Church, Virginia, May 18 (Photo by: Mark Oswell, MHS Communication)

Under Garrison's leadership, the OPT set-up 10 working groups, including the Services and Combatant Commands Synchronization Working Group, Vaccine Board, Allocations and Apportionment Board, Information Technology Working Group, Logistics Working Group, Joint Planning Group, Transition Working Group and others to execute this complex operational mission for the Secretary of Defense. The OPT also provided daily vaccine operations briefs to the COVID Task Force, DOD leadership, services, the Joint Staff and Combatant Commands to ensure smooth operations and strategic communications for successful mission accomplishment to all DOD eligible personnel.

Through the working groups, the OPT developed a multi-phased approach that began with planning and then transitioned to a pilot phase when vaccines became available under Emergency Use Authorization in early December.

"After planning, we went through a pilot phase, where we tested our ability to distribute the vaccines to 16 pilot sites, 12 inside the United States and four overseas," explained Garrison. "In conjunction with DOD leadership, the Joint Staff, Health Affairs, HHS and the CDC, we also conducted a vaccine distribution table top exercise to prove our concept for vaccine distribution and discover gaps within the plan. After the pilot and exercise, we were very confident in our ability to safely provide vaccines to our worldwide population."

The "expanded distribution" phase which lasted from January to May, began after the first 16 DOD vaccination pilot sites had been issued vaccine, and distribution, storage, administration, and reporting processes were validated. During this phase the OPT developed a process to equally and proportionally allocate the limited supply of vaccine to all the DOD populations, first by using a pro-rata based upon numbers of service members in the DOD population tiers, and later, pro-rata by the number of DOD eligible persons in geographic locations surrounding the DOD vaccination sites. In May 2021, as the amount of vaccine increased, the plan transitioned to the "saturation" phase.

"In this phase, DHA gave the responsibility over to the military services to place their vaccine orders based upon their demand," Garrison said.

The "saturation" phase closely resembled standard vaccine procedures in terms of requisition, distribution and allocation.

Air Force Col. (Dr.) Tonya Rans, medical lead for the OPT and team lead for the CVIP working group, explained how a vaccination ultimately results in a stronger, more medically ready force.

"Although the preventative practices the DOD instituted – masks, physical distancing, etc. – worked very well in keeping our population safe, its benefits stopped if there were lapses in practice. Offering an FDA-authorized COVID-19 vaccine, where initial and ongoing studies continue to demonstrate its safety and efficacy, provides longer protection," Rans said. "Those that have been vaccinated can now feel more comfortable that they will remain healthy from the COVID-19 disease while in environments where it is difficult to maintain other preventative measures."

Garrison expounded upon how proud she was with what the OPT was able to accomplish: "Aside from accomplishing the secretary of defense's priorities, they were also able to deliver the required amount of the vaccine to the various combatant commands, and as support the Military Health System in administering vaccines to the 12- to 17-year-old age group, she added.

The transition from the OPT to the CVIP working group signifies the successful development and implementation of the DOD's vaccination plan, but not the completion of the mission. Garrison explained how the mission of the OPT, and now the CVIP working group, always was and continues to be to get, "shots in arms as safely and quickly as possible."

She also articulated how none of this would have been possible without an inter-service effort and the personnel in the field. "We couldn't have done this without the Joint Staff, the services and the combatant commands supporting us in ensuring that all eligible DOD populations were getting the vaccine as fast as we could get it to them," said Garrison.

"The success of the DOD COVID-19 Vaccine Distribution Operation led by Lt. Gen. Place truly shows the value of the Defense Health Agency in its role as an operational combat support agency," concluded Garrison. "This endeavor highlights DHA's ability to bring together a successful and effective team and work with the services to support the needs of the Combatant Commands, and other DOD agencies and field activities."

You also may be interested in...

How COVID-19 Public Health Emergency’s End Affects TRICARE

Article Around MHS
5/16/2023
Immunization Clinic photo

The Public Health Emergency (PHE) for COVID-19 expired at the end of May 11. You might be wondering what this means about the state of COVID-19 or if there are changes to your TRICARE coverage.

COVID-19 Registry Provides Pandemic Response Insights, Optimizes Patient Care

Article
3/28/2023
COVID-19 Registry Provides Pandemic Response Insights, Optimizes Patient Care

Prior to the pandemic, the DOD began deploying MHS GENESIS, the new federal electronic health record, to improve health care outcomes for our service members, veterans, and their families. Critical enterprise needs quickly came to light to combat the impacts of the COVID-19 disease.

Navy’s Global Engagement Helps Identify and Mitigate Disease

Article
3/22/2023
Navy’s Global Engagement Helps Identify and Mitigate Disease

In support of the Military Health System, the Naval Medical Research Unit-2 is just one global entity that works with local partners to identify and combat global health threats.

Genome Sequencing Assists Research at Naval Health Research Center

Article
1/24/2023
Lab technicians doing genome research

Learn how unique samples from naval vessels, US-Mexico border populations, and DOD beneficiaries aided in the Naval Health Research Center’s sequencing efforts.

U.S. Military HIV Research Lends Lessons Learned to COVID-19

Article
1/19/2023
Gloved hands working in laboratory

The U.S. military has engaged in HIV research for three decades, contributing critical lessons learned, knowledge, and expertise during the COVID-19 research and vaccine development effort.

Naval Medical Research Center Uses Genome Sequencing for Variants

Article
1/12/2023
Military personnel pose for a group photo

NMRC’s efforts provided important support for sequencing and viral isolation to the Department of Defense and Military Health System.

USAMRIID Focuses on Genome Sequencing to Detect Variants

Article
1/5/2023
Military medical personnel in laboratory

A connected family of laboratories across the MHS allows a more rapid response to the outbreak.

Whole Genome Sequencing at Tripler Army Medical Center

Article
12/29/2022
Dr. Keith Fong reviews data with other lab technicians

The third installment in a 6-part series highlighting the efforts of the Military Health System laboratories and the technicians who worked to identify COVID-19 variants using special sequencing technology.

Walter Reed Army Institute of Research Implements SARS-CoV-2 Genome Sequencing

Article
12/23/2022
Military medical personnel in laboratory

This is the second article in a 6-part series that highlights the work of technicians and scientists in Military Health System laboratories who worked to identify COVID-19 variants using special sequencing technology.

Protect Yourself With Respiratory Illnesses on the Rise

Article Around MHS
12/19/2022
Military medical personnel administering vaccine

"Tis the season, and respiratory illnesses are on the rise. Learn critical health guidance about the viral triple threat of COVID-19, influenza, and the common cold, and the commonsense steps you can take to protect yourself and your family.

Military Labs Use Whole Genome Sequencing of COVID-19 Variants

Article
12/16/2022
Lab technician at work

The first in a 6-part series highlighting the work of technicians and scientists working in support of the MHS who identified COVID-19 variants using special sequencing technology.

DOD Reduces Health Care Waste by Reusing Crutches

Article
12/15/2022
Military personnel using crutches

When military facilities faced a national shortage of an essential mobility aid, they launched a grassroots initiative that not only ensured patient care, but also created a new waste reduction model within the DHA.

Flu Season’s Here: You Still Can Get Your Flu Shot for Protection

Article
12/12/2022
Flu Week Infographic

It’s not too late to get vaccinated against the flu and COVID-19.

MHS Minute | Nov 2022

Video
12/12/2022
MHS Minute | Nov 2022

The latest MHS Minute focuses on highlights from DHA Director Lt. Gen. Ronald J. Place’s final virtual town hall with the workforce, Nov. 16, 2022. The discussion included the agency’s biggest accomplishments over the past three years and the impact of COVID-19 on DHA’s reputation and approach to health care delivery.

Naval Medical Research Center Joint Study with Mount Sinai Uncovers Differences in COVID-19 Immune Response between the Sexes

Article Around MHS
12/5/2022
Amanda Cherry, research assistant, performing diagnostic testing at NMRC

A collaborative study between researchers at Naval Medical Research Center and the Icahn School of Medicine at Mount Sinai, and Princeton University has highlighted immune response differences in the coronavirus infection responses between male and female patients.

Page 1 of 25 , showing items 1 - 15
First < 1 2 3 4 5  ... > Last 
Refine your search
Last Updated: January 17, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery